Changes in extracellular activin A:follistatin ratio during differentiation of a mesenchymal progenitor cell line, ROB-C26 into osteoblasts and adipocytes

Life Sciences

Volumn 81, Issue 1, 2007, Pages 8-18

  Kawabata, Niki ^a   Kamiya, Naoko ^a   Suzuki, Naoto ^a   Matsumoto, Mitsuhiko ^a   Takagi, Minoru ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Activin A; Adipocyte; Follistatin; Mesenchymal progenitor; Osteoblast

Indexed keywords

ACTIVIN A; BONE MORPHOGENETIC PROTEIN 2; CYCLOHEXIMIDE; DEXAMETHASONE; FOLLISTATIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

ACTIVINS; ADIPOCYTES; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; FOLLISTATIN; MESENCHYMAL STEM CELLS; OSTEOBLASTS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 34249991765     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.04.011     Document Type: Article

References (43)

1. Abe Y., Abe T., Aida Y., Hara Y., and Maeda K. Follistatin restricts bone morphogenetic protein (BMP)-2 action on the differentiation of osteoblasts in fetal rat mandibular cells. Journal of Bone and Mineral Research 19 8 (2004) 1302-1307
2. Aoki H., Fujii M., Imamura T., Yagi K., Takehara K., Kato M., and Miyazono K. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. Journal of Cellular Science 114 8 (2001) 1483-1489
3. Boden S.D., McCuaig K., Hair G., Racine M., Titus L., Wozney J.M., and Nanes M.S. Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 137 8 (1996) 3401-3407
4. Canalis E., Economides A.N., and Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Reviews 24 2 (2003) 218-235
5. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 1 (1987) 156-159
6. Fajas L., Debril M.B., and Auwerx J. Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis. Journal of Molecular Endocrinology 27 1 (2001) 1-9
7. Funaba M., Murata T., Fujimura H., Murata E., Abe M., Takahashi M., and Torii K. Unique recognition of activin and inhibin by polyclonal antibodies to inhibin subunits. Journal of Biochemistry (Tokyo) 119 5 (1996) 953-960
8. Gaddy-Kurten D., Coker J.K., Abe E., Jilka R.L., and Manolagas S.C. Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 143 1 (2002) 74-83
9. Gazzerro E., Gangji V., and Canalis E. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. Journal of Clinical Investigation 102 12 (1998) 2106-2114
10. Gazit D., Ebner R., Kahn A.J., and Derynck R. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Molecular Endocrinology 7 2 (1993) 189-198
11. Glister C., Kemp C.F., and Knight P.G. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 127 2 (2004) 239-254
12. Harris S.E., Bonewald L.F., Harris M.A., Sabatini M., Dallas S., Feng J.Q., Ghosh-Choudhury N., Wozney J., and Mundy G.R. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. Journal of Bone and Mineral Research 9 6 (1994) 855-863
13. Harris S.E., Sabatini M., Harris M.A., Feng J.Q., Wozney J., and Mundy G.R. Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells. Journal of Bone and Mineral Research 9 3 (1994) 389-394
14. Hashimoto M., Shoda A., Inoue S., Yamada R., Kondo T., Sakurai T., Ueno N., and Muramatsu M. Functional regulation by osteoblastic cells by the interaction of activin-A with follistatin. Journal of Biological Chemistry 267 7 (1992) 4999-5004
15. Hirai S., Yamanaka M., Kawachi H., Matsui T., and Yano H. Activin A inhibits differentiation of 3T3-L1 preadipocyte. Molecular and Cellular Endocrinology 232 1-2 (2005) 21-26
16. Hughes F.J., Collyer J., Stanfield M., and Goodman S.A. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 136 6 (1995) 2671-2677
17. Iemura S., Yamamoto T.S., Takagi C., Uchiyama H., Natsume T., Shimasaki S., Sugino H., and Ueno N. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proceedings of the National Academy of Sciences USA 95 16 (1998) 9337-9342
18. Ito S., Suzuki N., Kato S., Takahashi T., and Takagi M. Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone 40 1 (2007) 84-92
19. Iu M.F., Kaji H., Sowa H., Naito J., Sugimoto T., and Chihara K. Dexamethasone suppresses Smad3 pathway in osteoblastic cells. Journal of Endocrinology 185 1 (2005) 131-138
20. Kassel O., Schmidlin F., Duvernelle C., de Blay F., and Frossard N. Up- and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture. Molecular Pharmacology 54 6 (1998) 1073-1079
21. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., and Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. Journal of Cell Biology 127 6 Pt 1 (1994) 1755-1766
22. Kearns A.E., and Demay M.B. BMP-2 induces the expression of activin betaA and follistatin in vitro. Journal of Cellular Biochemistry 79 1 (2000) 80-88
23. Kim Y.J., Lee M.H., Wozney J.M., Cho J.Y., and Ryoo H.M. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. Journal of Biological Chemistry 279 49 (2004) 50773-50780
24. Kim S.W., Her S.J., Kim S.Y., and Shin C.S. Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochemical and Biophysical Research Communication 327 3 (2005) 811-819
25. Kirk M.D., and Kahn A.J. Extracellular matrix synthesized by clonal osteogenic cells is osteoinductive in vivo and in vitro: role of transforming growth factor-beta 1 in osteoblast cell-matrix interaction. Journal of Bone and Mineral Research 10 8 (1995) 1203-1208
26. Leclerc N., Luppen C.A., Ho V.V., Nagpal S., Hacia J.G., Smith E., and Frenkel B. Gene expression profiling of glucocorticoid-inhibited osteoblasts. Journal of Molecular Endocrinology 33 1 (2004) 175-193
27. Lee M.H., Kwon T.G., Park H.S., Wozney J.M., and Ryoo H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochemical and Biophysical Research Communication 309 3 (2003) 689-694
28. Lin S.Y., Morrison J.R., Phillips D.J., and de Kretser D.M. Regulation of ovarian function by the TGF-beta superfamily and follistatin. Reproduction 126 2 (2003) 133-148
29. Mellor S.L., Cranfield M., Ries R., Pedersen J., Cancilla B., de Kretser D., Groome N.P., Mason A.J., and Risbridger G.P. Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit. Journal of Clinical Endocrinology and Metabolism 85 12 (2000) 4851-4858
30. Michel U., Albiston A., and Findlay J.K. Rat follistatin: gonadal and extragonadal expression and evidence for alternative splicing. Biochemical and Biophysical Research Communication 173 1 (1990) 401-407
31. Nakamura T., Takio K., Eto Y., Shibai H., Titani K., and Sugino H. Activin-binding protein from rat ovary is follistatin. Science 247 4944 (1990) 836-838
32. Ogata Y., Yamauchi M., Kim R.H., Li J.J., Freedman L.P., and Sodek J. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter. European Journal of Biochemistry 230 1 (1995) 183-192
33. Ogawa Y., Schmidt D.K., Nathan R.M., Armstrong R.M., Miller K.L., Sawamura S.J., Ziman J.M., Erickson K.L., de Leon E.R., Rosen D.M., Seyedin S.M., Glaser C.B., Chang R.J., Corrigan A.Z., Vale, and Wylie. Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation. Journal of Biological Chemistry 267 20 (1992) 14233-14237
34. Ohnishi N., Miyata T., Ohnishi H., Yasuda H., Tamada K., Ueda N., Mashima H., and Sugano K. Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut 52 10 (2003) 1487-1493
35. Partridge N.C., Alcorn D., Michelangeli V.P., Kemp B.E., Ryan G.B., and Martin T.J. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology 108 1 (1981) 213-219
36. Pereira R.C., Economides A.N., and Canalis E. Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts. Endocrinology 141 12 (2000) 4558-4563
37. Sakai R., and Eto Y. Involvement of activin in the regulation of bone metabolism. Molecular and Cellular Endocrinology 180 1-2 (2001) 183-188
38. Sakai R., Miwa K., and Eto Y. Local administration of activin promotes fracture healing in the rat fibula fracture model. Bone 25 2 (1999) 191-196
39. Sakai R., Fujita S., Horie T., Ohyama T., Miwa K., Maki T., Okimoto N., Nakamura T., and Eto Y. Activin increases bone mass and mechanical strength of lumbar vertebrae in aged ovariectomized rats. Bone 27 1 (2000) 91-96
40. Yamaguchi A., and Kahn A.J. Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcified Tissue International 49 3 (1991) 221-225
41. Yamaguchi A., Katagiri T., Ikeda T., Wozney J.M., Rosen V., Wang E.A., Kahn A.J., Suda T., and Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. Journal of Cell Biology 113 3 (1991) 681-687
42. Yamaguchi A., Komori T., and Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, Hedgehogs, and cbfa1. Endocrine Reviews 21 4 (2000) 393-411
43. Yamashita H., ten Dijke P., Huylebroeck D., Sampath T.K., Andries M., Smith J.C., Heldin C.H., and Miyazono K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. Journal of Cell Biology 130 1 (1995) 217-226